1. Design, Synthesis, and Characterization of Cinnamic Acid Derivatives with Two Novel Acrylohydrazones on HeLa and CHO-1 Cancer Cell Lines: The Experimental and Computational Perspective
- Author
-
Ogunlakin, Akingbolabo Daniel, Sonibare, Mubo Adeola, Yeye, Oloruntoba Emmanuel, Jabeen, Almas, Shah, Syeda Farah, Ojo, Oluwafemi Adeleke, Gyebi, Gideon Ampoma, and Ayokunle, Damilare IyinKristi
- Abstract
Purpose: To investigate the effect of derivatives of cinnamic acid on the proliferation of CHO-1 and HeLa cell lines. Methods: Three Acrylohydrazones (7–9) derived from cinnamic acid hydrazides (6) as well as five cinnamic acid derivatives were studied in the current study (1–5). All the synthesized compounds were characterized by physical and spectral data. Two of the synthesized acrylohydrazones compounds (8 and 9) were novel. The antiproliferative activity of these compounds on cervical adenocarcinoma (HeLa) and Chinese Hamster Ovarian (CHO-1) cells, with abnormal p53tumour suppressor gene, was investigated. The compounds were also studied through molecular docking and molecular dynamics (MD) simulation for possible interaction with important therapeutic targets (PDB: 3PP0 and 3EQM for HeLa and 2OCJ and 3ZME for CHO). Results: Compound 7exhibits the highest inhibitory effect on the CHO-1 cancer cell line with an IC50 = 4.2 ± 0.6 µg/mL as compared with the standard doxorubicin (IC50 = 0.8 ± 0.01 µg/mL) and demonstrates a weak inhibitory effect on the HeLa cell line. Compounds 1–5 had no inhibitory activity on the CHO-1 cell line, while compounds 7and 9were moderately toxic to the two cell lines. The acrylohydrazones (7–9) demonstrated the highest binding tendencies to the target proteins. Also, the lead compounds (compounds 7–9) complexed with the protein targets were stable in a 100 ns MD simulation. Conclusion: Therefore, the acrylohydrazones (compounds 7–9)would be of interest in the treatment/management of ovarian and cervical cancer among women.
- Published
- 2024
- Full Text
- View/download PDF